British lawmakers are calling for greater oversight of Palantir Technologies’ NHS data contracts after new guidance mandated all hospitals adopt the controversial US firm’s software by June 2024. The move has reignited debates about patient privacy and the appropriate role of private tech firms in public healthcare systems.
The NHS directive, quietly issued last month, would centralize hospital operations data through Palantir’s Foundry platform. While health officials claim this will improve efficiency, critics point to the company’s ties to defense and intelligence agencies. “There hasn’t been proper parliamentary scrutiny of what amounts to a wholesale handover of sensitive medical data,” said one MP speaking anonymously due to ongoing inquiries.
Palantir maintains its systems meet UK data protection standards, with a spokesperson stating: “Our technology helps clinicians reduce waiting times while maintaining strict access controls.” However, internal NHS documents obtained by the BBC reveal at least five hospital trusts have resisted implementation over security concerns.
The controversy comes as the UK government accelerates digital health initiatives. Analysts suggest the rushed rollout may face legal challenges under GDPR provisions regarding third-party data processors. “This sets a dangerous precedent for healthcare privatization,” warned a Data Protection Officer at a major London hospital.